

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.00680453 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.00680453 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.84030960 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.84030960 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.84030960 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.84030960 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.84030960 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.84030960 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.65858867 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.56118125 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.55985065 |
| 12 | response to peptidoglycan (GO:0032494) | 5.29764365 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 5.19976488 |
| 14 | detection of other organism (GO:0098543) | 5.10716711 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 5.02610223 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.93717376 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.86153250 |
| 18 | detection of bacterium (GO:0016045) | 4.81738335 |
| 19 | leukocyte aggregation (GO:0070486) | 4.57164763 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 4.55397274 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.46120088 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.43337123 |
| 23 | cellular extravasation (GO:0045123) | 4.40181920 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.35083659 |
| 25 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.30720758 |
| 26 | neutrophil activation (GO:0042119) | 4.28877762 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.28333096 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.19926236 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 4.16881801 |
| 30 | respiratory burst (GO:0045730) | 4.07250082 |
| 31 | granulocyte activation (GO:0036230) | 4.06002612 |
| 32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.01166018 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.97550584 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.96169447 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.95738268 |
| 36 | response to host immune response (GO:0052572) | 3.95738268 |
| 37 | detection of biotic stimulus (GO:0009595) | 3.92038058 |
| 38 | microglial cell activation (GO:0001774) | 3.90218882 |
| 39 | macrophage activation (GO:0042116) | 3.81585868 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.76512456 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.76125019 |
| 42 | type I interferon signaling pathway (GO:0060337) | 3.65093281 |
| 43 | cellular response to type I interferon (GO:0071357) | 3.65093281 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.62746234 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.61742960 |
| 46 | response to type I interferon (GO:0034340) | 3.61712474 |
| 47 | response to host (GO:0075136) | 3.60793663 |
| 48 | response to host defenses (GO:0052200) | 3.60793663 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.60793663 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.58402835 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56036384 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.48891408 |
| 53 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.47876547 |
| 54 | response to interleukin-15 (GO:0070672) | 3.47828902 |
| 55 | positive regulation of mast cell activation (GO:0033005) | 3.46373943 |
| 56 | germinal center formation (GO:0002467) | 3.46306285 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.43611849 |
| 58 | regulation of T cell tolerance induction (GO:0002664) | 3.43204265 |
| 59 | defense response to protozoan (GO:0042832) | 3.41697712 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.41539362 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.40498124 |
| 62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.35719166 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.32923597 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.32768044 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 3.31950008 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30653064 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.29844981 |
| 68 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.24163671 |
| 69 | B cell mediated immunity (GO:0019724) | 3.23533565 |
| 70 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.18329658 |
| 71 | cellular response to interleukin-15 (GO:0071350) | 3.13078167 |
| 72 | myeloid leukocyte mediated immunity (GO:0002444) | 3.12648571 |
| 73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.11679681 |
| 74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11443272 |
| 75 | positive regulation of interferon-alpha production (GO:0032727) | 3.11045519 |
| 76 | leukocyte degranulation (GO:0043299) | 3.10439619 |
| 77 | regulation of interferon-alpha production (GO:0032647) | 3.09742191 |
| 78 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09644719 |
| 79 | response to protozoan (GO:0001562) | 3.08155916 |
| 80 | positive regulation of mast cell degranulation (GO:0043306) | 3.06606460 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.06606460 |
| 82 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.06200058 |
| 83 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.03805974 |
| 84 | neutrophil chemotaxis (GO:0030593) | 3.01460492 |
| 85 | negative regulation of interleukin-6 production (GO:0032715) | 2.98159591 |
| 86 | positive regulation of type 2 immune response (GO:0002830) | 2.97011075 |
| 87 | myeloid leukocyte activation (GO:0002274) | 2.95617723 |
| 88 | neutrophil migration (GO:1990266) | 2.93644220 |
| 89 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.92785729 |
| 90 | negative regulation of innate immune response (GO:0045824) | 2.92470464 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 2.92058221 |
| 92 | T-helper 1 type immune response (GO:0042088) | 2.91788438 |
| 93 | negative regulation of type 2 immune response (GO:0002829) | 2.90427425 |
| 94 | regulation of regulated secretory pathway (GO:1903305) | 2.87698261 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.87266765 |
| 96 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.87266765 |
| 97 | B cell receptor signaling pathway (GO:0050853) | 2.87025631 |
| 98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.86874959 |
| 99 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.86752938 |
| 100 | dendritic cell chemotaxis (GO:0002407) | 2.85516136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.55360915 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.99248479 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.65294532 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.64464964 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.56727518 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.43695934 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42381673 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.06567949 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.00148826 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.97279194 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88952295 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.84317774 |
| 13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.68047053 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67117463 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.65041011 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.59847533 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.57396496 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57110038 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45703222 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.41956938 |
| 21 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38534076 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29624205 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.23914560 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19379354 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18711125 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.17919723 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.17711576 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.15983881 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12176441 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.08738552 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 2.06591613 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05285788 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96421278 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.95226234 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.90704450 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.89542273 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85768809 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.83397239 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82226332 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78862219 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.77423699 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77031889 |
| 43 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65958097 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64360546 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64168405 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63953267 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.62876559 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58048230 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52886253 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50047576 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49762472 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49553668 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49042061 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44576464 |
| 55 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42699430 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40516962 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38520197 |
| 58 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37078798 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37037513 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35786266 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35027362 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33988815 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29792614 |
| 64 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29673686 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29339856 |
| 66 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28890671 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27979263 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27937809 |
| 69 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25669543 |
| 70 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25575959 |
| 71 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19891914 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19339266 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17942326 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16671448 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16608670 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15807501 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14345514 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12470066 |
| 79 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09530794 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08785340 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08735159 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08121454 |
| 83 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04635829 |
| 84 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.02651382 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00623435 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99844485 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99793777 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99328420 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96933276 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90022402 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89837093 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89207215 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86029614 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84347603 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83087334 |
| 96 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81966832 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80047128 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74963936 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.74051373 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 0.73132468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.17216474 |
| 2 | MP0003303_peritoneal_inflammation | 4.45620005 |
| 3 | MP0003436_decreased_susceptibility_to | 4.30933412 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.68272037 |
| 5 | MP0002419_abnormal_innate_immunity | 3.24686940 |
| 6 | MP0009785_altered_susceptibility_to | 3.12464195 |
| 7 | MP0006082_CNS_inflammation | 3.11752418 |
| 8 | MP0005025_abnormal_response_to | 2.95283342 |
| 9 | MP0005671_abnormal_response_to | 2.91362192 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.87744728 |
| 11 | MP0001790_abnormal_immune_system | 2.85974689 |
| 12 | MP0005387_immune_system_phenotype | 2.85974689 |
| 13 | MP0001800_abnormal_humoral_immune | 2.74708285 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.65951826 |
| 15 | MP0000685_abnormal_immune_system | 2.61931160 |
| 16 | MP0002723_abnormal_immune_serum | 2.55481406 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.51608191 |
| 18 | * MP0002452_abnormal_antigen_presenting | 2.46667238 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.38940030 |
| 20 | * MP0001819_abnormal_immune_cell | 2.37252002 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.30403707 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.27254172 |
| 23 | MP0002405_respiratory_system_inflammati | 1.98438139 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.96197590 |
| 25 | MP0009278_abnormal_bone_marrow | 1.92594279 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.89289957 |
| 27 | MP0004510_myositis | 1.89099632 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.83162499 |
| 29 | MP0008260_abnormal_autophagy | 1.82574859 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.80762324 |
| 31 | MP0009764_decreased_sensitivity_to | 1.78951750 |
| 32 | MP0004947_skin_inflammation | 1.75319241 |
| 33 | * MP0000716_abnormal_immune_system | 1.73115622 |
| 34 | MP0005451_abnormal_body_composition | 1.71330499 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.71276251 |
| 36 | MP0003828_pulmonary_edema | 1.68379245 |
| 37 | * MP0002398_abnormal_bone_marrow | 1.66899143 |
| 38 | MP0003075_altered_response_to | 1.64262408 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.63346572 |
| 40 | MP0002132_abnormal_respiratory_system | 1.59539723 |
| 41 | MP0008469_abnormal_protein_level | 1.57238680 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.48288327 |
| 43 | MP0005310_abnormal_salivary_gland | 1.44093898 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.41523211 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.41158788 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.40588089 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.40331770 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.40331770 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.39980224 |
| 50 | MP0002722_abnormal_immune_system | 1.38937606 |
| 51 | MP0000858_altered_metastatic_potential | 1.37472065 |
| 52 | MP0003690_abnormal_glial_cell | 1.36105075 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.35564616 |
| 54 | * MP0002429_abnormal_blood_cell | 1.34513812 |
| 55 | MP0004883_abnormal_blood_vessel | 1.33185509 |
| 56 | MP0000343_altered_response_to | 1.29456912 |
| 57 | MP0003866_abnormal_defecation | 1.26828854 |
| 58 | MP0008004_abnormal_stomach_pH | 1.26132118 |
| 59 | MP0005164_abnormal_response_to | 1.17902908 |
| 60 | MP0005166_decreased_susceptibility_to | 1.17834306 |
| 61 | MP0001851_eye_inflammation | 1.17346953 |
| 62 | MP0003448_altered_tumor_morphology | 1.12831620 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.10680530 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.10498373 |
| 65 | MP0001853_heart_inflammation | 1.05800447 |
| 66 | MP0000604_amyloidosis | 1.04516652 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.03451796 |
| 68 | MP0004381_abnormal_hair_follicle | 1.00167251 |
| 69 | MP0005390_skeleton_phenotype | 0.94373238 |
| 70 | MP0009763_increased_sensitivity_to | 0.90494717 |
| 71 | MP0009840_abnormal_foam_cell | 0.89270034 |
| 72 | MP0001663_abnormal_digestive_system | 0.84763893 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.80764886 |
| 74 | MP0002332_abnormal_exercise_endurance | 0.80679810 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.74584241 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.73674902 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 0.69524491 |
| 78 | MP0008874_decreased_physiological_sensi | 0.68564476 |
| 79 | MP0000490_abnormal_crypts_of | 0.68082308 |
| 80 | MP0003795_abnormal_bone_structure | 0.67824062 |
| 81 | MP0003045_fibrosis | 0.67495312 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 0.66445774 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.65467078 |
| 84 | MP0001873_stomach_inflammation | 0.65127788 |
| 85 | MP0002933_joint_inflammation | 0.64252089 |
| 86 | MP0000249_abnormal_blood_vessel | 0.62190381 |
| 87 | MP0002166_altered_tumor_susceptibility | 0.61469104 |
| 88 | MP0006054_spinal_hemorrhage | 0.60523692 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60359706 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.60320806 |
| 91 | MP0000920_abnormal_myelination | 0.59153247 |
| 92 | MP0003091_abnormal_cell_migration | 0.57379092 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.57232564 |
| 94 | MP0002254_reproductive_system_inflammat | 0.57189144 |
| 95 | MP0004858_abnormal_nervous_system | 0.55253637 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.51252867 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.49617430 |
| 98 | MP0004130_abnormal_muscle_cell | 0.48124107 |
| 99 | MP0003329_amyloid_beta_deposits | 0.46613215 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.46529975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.73348512 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.11089326 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.08544370 |
| 4 | Myositis (HP:0100614) | 6.07639729 |
| 5 | Orchitis (HP:0100796) | 5.98367084 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.92077683 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.68957847 |
| 8 | Optic neuritis (HP:0100653) | 5.68957847 |
| 9 | Stomatitis (HP:0010280) | 5.14323790 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.14161193 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.52707025 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.28540395 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.09299893 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 4.08865206 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.07660682 |
| 16 | Obstructive lung disease (HP:0006536) | 4.07660682 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.97384403 |
| 18 | Recurrent skin infections (HP:0001581) | 3.85507422 |
| 19 | Meningitis (HP:0001287) | 3.78935911 |
| 20 | Keratoconjunctivitis (HP:0001096) | 3.78640027 |
| 21 | Encephalitis (HP:0002383) | 3.62402116 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.49382377 |
| 23 | Gingivitis (HP:0000230) | 3.49281165 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.48676533 |
| 25 | Vasculitis (HP:0002633) | 3.48171610 |
| 26 | Increased IgE level (HP:0003212) | 3.44359823 |
| 27 | Urticaria (HP:0001025) | 3.40982841 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.25768850 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.25768850 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.25768850 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.25179475 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.25179475 |
| 33 | Episodic fever (HP:0001954) | 3.18086578 |
| 34 | Hemoptysis (HP:0002105) | 3.14956532 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.12607366 |
| 36 | Amyloidosis (HP:0011034) | 3.04054240 |
| 37 | Prolonged bleeding time (HP:0003010) | 3.02648822 |
| 38 | Chest pain (HP:0100749) | 3.01220043 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.00828355 |
| 40 | Cellulitis (HP:0100658) | 2.94281740 |
| 41 | Anorexia (HP:0002039) | 2.90827426 |
| 42 | Arterial thrombosis (HP:0004420) | 2.90153581 |
| 43 | Peritonitis (HP:0002586) | 2.87640509 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.87556227 |
| 45 | T lymphocytopenia (HP:0005403) | 2.80330993 |
| 46 | Leukocytosis (HP:0001974) | 2.79750646 |
| 47 | Gingival bleeding (HP:0000225) | 2.74111541 |
| 48 | Hypochromic anemia (HP:0001931) | 2.74037592 |
| 49 | Loss of speech (HP:0002371) | 2.72151736 |
| 50 | Pulmonary embolism (HP:0002204) | 2.70282939 |
| 51 | Increased IgM level (HP:0003496) | 2.69107740 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.67955149 |
| 53 | Petechiae (HP:0000967) | 2.67035444 |
| 54 | Recurrent viral infections (HP:0004429) | 2.62510799 |
| 55 | Gangrene (HP:0100758) | 2.61144186 |
| 56 | Epistaxis (HP:0000421) | 2.55065431 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.47464391 |
| 58 | Purpura (HP:0000979) | 2.44779501 |
| 59 | Abnormality of the pleura (HP:0002103) | 2.43687596 |
| 60 | Gastrointestinal inflammation (HP:0004386) | 2.37274081 |
| 61 | Increased serum ferritin (HP:0003281) | 2.36141642 |
| 62 | Osteomyelitis (HP:0002754) | 2.34833626 |
| 63 | Disinhibition (HP:0000734) | 2.34499325 |
| 64 | Pustule (HP:0200039) | 2.34233259 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28375341 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.28111846 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.25835666 |
| 68 | Abnormality of T cells (HP:0002843) | 2.24118869 |
| 69 | Sepsis (HP:0100806) | 2.24057360 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.23170292 |
| 71 | Granulocytopenia (HP:0001913) | 2.22061595 |
| 72 | Abnormality of the peritoneum (HP:0002585) | 2.19777742 |
| 73 | Abnormality of the endocardium (HP:0004306) | 2.19104806 |
| 74 | Vertigo (HP:0002321) | 2.18553514 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.18343818 |
| 76 | Glomerulopathy (HP:0100820) | 2.16609245 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.16265569 |
| 78 | Acne (HP:0001061) | 2.14241641 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 2.13155342 |
| 80 | Premature loss of primary teeth (HP:0006323) | 2.12626563 |
| 81 | Abnormality of the pericardium (HP:0001697) | 2.10796182 |
| 82 | Polyneuropathy (HP:0001271) | 2.09032572 |
| 83 | Lymphopenia (HP:0001888) | 2.07708838 |
| 84 | Keratitis (HP:0000491) | 2.07693494 |
| 85 | Microcytic anemia (HP:0001935) | 2.05579525 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.03979096 |
| 87 | Panhypogammaglobulinemia (HP:0003139) | 2.03584500 |
| 88 | Colitis (HP:0002583) | 2.00403772 |
| 89 | Vacuolated lymphocytes (HP:0001922) | 1.97668582 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94555522 |
| 91 | Skin ulcer (HP:0200042) | 1.90895194 |
| 92 | Eosinophilia (HP:0001880) | 1.89346145 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 1.87991572 |
| 94 | Slow saccadic eye movements (HP:0000514) | 1.85590087 |
| 95 | Chronic otitis media (HP:0000389) | 1.84086212 |
| 96 | Recurrent pneumonia (HP:0006532) | 1.83224151 |
| 97 | Hematochezia (HP:0002573) | 1.82938601 |
| 98 | Abnormality of T cell physiology (HP:0011840) | 1.82741767 |
| 99 | Malnutrition (HP:0004395) | 1.79430749 |
| 100 | Arthralgia (HP:0002829) | 1.79135269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.84487187 |
| 2 | BLK | 3.39795944 |
| 3 | MAP4K1 | 3.31260306 |
| 4 | IRAK4 | 3.31126555 |
| 5 | MAP2K3 | 3.02311504 |
| 6 | TYK2 | 2.95478702 |
| 7 | ERN1 | 2.92678120 |
| 8 | CSK | 2.86391679 |
| 9 | FES | 2.29004047 |
| 10 | TNK2 | 2.20410096 |
| 11 | PRPF4B | 2.20409767 |
| 12 | TAOK1 | 2.14115649 |
| 13 | EPHB1 | 2.06773093 |
| 14 | ZAP70 | 2.06635854 |
| 15 | MAP3K3 | 2.06416471 |
| 16 | FGR | 2.04134928 |
| 17 | MAP3K14 | 1.93018348 |
| 18 | GRK6 | 1.87467352 |
| 19 | MAP3K11 | 1.86553282 |
| 20 | JAK3 | 1.83166306 |
| 21 | TXK | 1.81229399 |
| 22 | HCK | 1.67466208 |
| 23 | BTK | 1.64190349 |
| 24 | TBK1 | 1.62929859 |
| 25 | IKBKE | 1.60895963 |
| 26 | SYK | 1.55137464 |
| 27 | JAK2 | 1.46211648 |
| 28 | MATK | 1.40502917 |
| 29 | LYN | 1.39010984 |
| 30 | SIK3 | 1.38790208 |
| 31 | MAP3K1 | 1.34677736 |
| 32 | TAOK2 | 1.34524176 |
| 33 | MAP3K13 | 1.32230452 |
| 34 | JAK1 | 1.32004139 |
| 35 | KSR2 | 1.19986615 |
| 36 | YES1 | 1.13375500 |
| 37 | CSF1R | 1.12869781 |
| 38 | IRAK3 | 1.11549907 |
| 39 | LCK | 1.11483068 |
| 40 | IRAK1 | 1.10691730 |
| 41 | GRK7 | 1.09336353 |
| 42 | MARK3 | 1.05353324 |
| 43 | IKBKB | 1.05193311 |
| 44 | IRAK2 | 1.03720978 |
| 45 | TAOK3 | 1.02261583 |
| 46 | KIT | 1.00861070 |
| 47 | BMPR2 | 1.00442469 |
| 48 | TGFBR2 | 0.98171016 |
| 49 | MARK2 | 0.95764629 |
| 50 | PRKD2 | 0.90509158 |
| 51 | STK10 | 0.90043613 |
| 52 | TESK2 | 0.85560763 |
| 53 | PTK6 | 0.83911191 |
| 54 | CDC42BPA | 0.83282860 |
| 55 | PDK1 | 0.83269608 |
| 56 | SIK2 | 0.82479543 |
| 57 | ITK | 0.81108459 |
| 58 | PDPK1 | 0.76587082 |
| 59 | MAP3K6 | 0.75464461 |
| 60 | TRIB3 | 0.71978278 |
| 61 | MAP3K5 | 0.70956070 |
| 62 | TEC | 0.68952997 |
| 63 | EPHA3 | 0.66169235 |
| 64 | FYN | 0.65004670 |
| 65 | MOS | 0.58624785 |
| 66 | CDK19 | 0.56924118 |
| 67 | MAPK7 | 0.55482199 |
| 68 | DYRK1B | 0.55174817 |
| 69 | MAP2K4 | 0.54452685 |
| 70 | MAPK12 | 0.52835181 |
| 71 | LRRK2 | 0.52832977 |
| 72 | DAPK2 | 0.51960871 |
| 73 | MAP3K2 | 0.50198646 |
| 74 | MAP3K7 | 0.50043881 |
| 75 | SIK1 | 0.49432197 |
| 76 | PTK2B | 0.48323991 |
| 77 | MAP2K6 | 0.48126063 |
| 78 | RIPK1 | 0.47954137 |
| 79 | FGFR4 | 0.47641626 |
| 80 | STK11 | 0.47125853 |
| 81 | HIPK2 | 0.46232235 |
| 82 | RPS6KL1 | 0.46038893 |
| 83 | RPS6KC1 | 0.46038893 |
| 84 | FGFR3 | 0.45510189 |
| 85 | SGK3 | 0.45253022 |
| 86 | SMG1 | 0.43557034 |
| 87 | PIM1 | 0.42006122 |
| 88 | PRKCQ | 0.41123889 |
| 89 | KSR1 | 0.38503669 |
| 90 | RPS6KA6 | 0.38097839 |
| 91 | MAPKAPK2 | 0.36479221 |
| 92 | PIK3CG | 0.35520604 |
| 93 | RAF1 | 0.34719924 |
| 94 | PRKG2 | 0.33735097 |
| 95 | DYRK3 | 0.33499414 |
| 96 | RET | 0.32389554 |
| 97 | STK38 | 0.31800725 |
| 98 | CHUK | 0.29431350 |
| 99 | PRKCZ | 0.28937955 |
| 100 | PRKCD | 0.28463418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 3.10553496 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.07919856 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.99425071 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.39725613 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.35736893 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.33899078 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.28884306 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.14607883 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.12755955 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.10673309 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.06402281 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01368998 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.94611957 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92114698 |
| 15 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86444558 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.79863324 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.79578716 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73517051 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68484143 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.68268485 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.67986430 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64491939 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.59723827 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59184468 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.58108023 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56558240 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54825280 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.53966182 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.53439463 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53301265 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53300924 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.51918651 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47663135 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47352827 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.43743459 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43457976 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38913733 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.38795257 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38243087 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35525496 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33815027 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.24837883 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.23605274 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12737162 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.12208676 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.11449957 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09922850 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.04135072 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04060553 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01766611 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97522268 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.96364260 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.90442710 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89899172 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88198762 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88085136 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82186855 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81763671 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77640786 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76072096 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.75876225 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74489875 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74180518 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72026791 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.71959912 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70696608 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68605590 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66849055 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65918826 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64184055 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64081450 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59580252 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56908065 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56770191 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56559120 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51452023 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50995799 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50542438 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50438479 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48116635 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46696194 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46203542 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.44601238 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44214537 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43334250 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42946351 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41978010 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41611918 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40128539 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39195101 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.38739498 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38595642 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37646454 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36649482 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35537887 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34621289 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34082883 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33800445 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31233021 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30385202 |

